Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FSGS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05599815
What this trial is testing

Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Aldeyra Therapeutics, Inc.
Large-scale testing (Phase 3)UnknownNCT02896270
What this trial is testing

Valproic Acid for Idiopathic Nephrotic Syndrome

Who this might be right for
Idiopathic Nephrotic SyndromeFocal Segmental GlomerulosclerosisMinimal Change Disease
Universitair Ziekenhuis Brussel 15
Testing effectiveness (Phase 2)Looking for participantsNCT07614477
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases

Who this might be right for
Minimal Change Disease (MCD)IgA Nephropathy (IgAN)Focal Segmental Glomerulosclerosis (FSGS)
Everest Medicines (China) Co.,Ltd. 45
Not applicableLooking for participantsNCT06334692
What this trial is testing

Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Mario Negri Institute for Pharmacological Research 100
Not applicableStudy completedNCT04389827
What this trial is testing

Global Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
The George Institute 5,999
Not applicableLooking for participantsNCT01605266
What this trial is testing

INSIGHT (Insight Into Nephrotic Syndrome)

Who this might be right for
Nephrotic Syndrome
The Hospital for Sick Children 1,000
Post-approval studies (Phase 4)Study completedNCT01129284
What this trial is testing

Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)

Who this might be right for
Treatment Resistant Nephrotic Syndrome
Columbia University 15
Not applicableLooking for participantsNCT05036850
What this trial is testing

China Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
George (Beijing) Clinical Research Co. Ltd. 1,200
Not applicableLooking for participantsNCT03929887
What this trial is testing

KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis

Who this might be right for
Glomerular DiseaseMinimal Change DiseaseIgA Nephropathy+4 more
Seoul National University Hospital 3,000
Post-approval studies (Phase 4)Study completedNCT02585804
What this trial is testing

Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects

Who this might be right for
Focal Segmental Glomerulosclerosis
University Health Network, Toronto 10
Testing effectiveness (Phase 2)Ended earlyNCT04387448
What this trial is testing

TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease

Who this might be right for
Kidney DiseasesDiabetic NephropathiesGlomerulosclerosis, Focal Segmental+8 more
Goldfinch Bio, Inc. 96
Testing effectiveness (Phase 2)Study completedNCT03366337
What this trial is testing

Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX

Who this might be right for
IgA NephropathyCKD Associated With Type 1 DiabetesFocal Segmental Glomerulosclerosis+1 more
Biogen 103
Large-scale testing (Phase 3)UnknownNCT03298698
What this trial is testing

Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome

Who this might be right for
Idiopathic Nephrotic SyndromeMinimal Change DiseaseFocal Segmental Glomerulosclerosis
Radboud University Medical Center 40
Not applicableLooking for participantsNCT04924712
What this trial is testing

INS, B Cells and Microbiota

Who this might be right for
MicrobiotaB-lymphocytesGlomerulosclerosis+1 more
Nantes University Hospital 30
Not applicableLooking for participantsNCT06760845
What this trial is testing

Raman Spectroscopy Diagnosis of Kidney Diseases

Who this might be right for
IgA Nephropathy (IgAN)Membranous NephropathyDiabetic Nephropathy+1 more
Zunsong Wang 200
Not applicableLooking for participantsNCT06162546
What this trial is testing

ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank

Who this might be right for
Focal Segmental GlomerulosclerosisProteinuriaNephrotic Syndrome+1 more
Christoph Aufricht 100
Post-approval studies (Phase 4)Active Not RecruitingNCT07219121
What this trial is testing

Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis

Who this might be right for
ProteinuriaImmunoglobulin A (IgA) NephropathyFocal Segmental Glomerulosclerosis+1 more
Travere Therapeutics, Inc. 20
Not applicableLooking for participantsNCT05650619
What this trial is testing

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseFSGS+1 more
University of Michigan 300
Not applicableStudy completedNCT04369183
What this trial is testing

Rituximab for Refractory or Relapsed Focal Segmental Glomerulosclerosis or Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change Disease
Istanbul University 25
Not applicableEnded earlyNCT04235621
What this trial is testing

Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

Who this might be right for
Glomerulosclerosis, Focal SegmentalMinimal Change DiseaseDiabetic Nephropathies
Goldfinch Bio, Inc. 20
Next Page